Dr Sandra S Ratliff, MD | |
582 Blue Ridge Ave, Bedford, VA 24523 | |
(540) 425-7910 | |
Not Available |
Full Name | Dr Sandra S Ratliff |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 582 Blue Ridge Ave, Bedford, Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750373544 | NPI | - | NPPES |
SM597491 | Other | PA | HIGHMARK BLUE SHIELD |
0011973400004 | Medicaid | PA | |
01952201 | Other | PA | CAIC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 0101260514 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Sandra S Ratliff, MD 582 Blue Ridge Ave, Bedford, VA 24523-2604 Ph: (540) 425-7910 | Dr Sandra S Ratliff, MD 582 Blue Ridge Ave, Bedford, VA 24523 Ph: (540) 425-7910 |
News Archive
ABC News interviewed President Barack Obama, who said: "The Senate certainly shouldn't try to jam anything through until Scott Brown is seated. People in Massachusetts spoke. He's got to be part of that process. ... I think point number two is that it is very important to look at the substance of this package and for the American people to understand that a lot of the fear mongering around this bill isn't true. I would advise that we try to move quickly to coalesce around those elements of the package that people agree on" (Stephanopoulos, 1/20).
ATMI, Inc. today unveiled an important extension to its Integrity™ product line for the biopharmaceutical and biotechnology industries with the introduction of a new range of single-use bioprocess vessels (BPVs). The Integrity BPVs were launched at the IBC Single-Use Applications for Biopharmaceutical Manufacturing event, taking place now through Wednesday, June 16, 2010.
W. L. Gore & Associates (Gore) today announced it has received European CE Mark approval for an expanded indication of the GORE® VIABIL® Biliary Endoprosthesis that allows removal of the device up to 12 months after implantation for the treatment of benign or malignant biliary strictures. The GORE® VIABIL® Biliary Endoprosthesis first received CE Mark approval in December 1999 and U.S. Food and Drug Administration (FDA) approval in January 2002 for the treatment of biliary strictures due to malignant neoplasms.
The podiatry practice of Mark E. Spier, DPM, announced today that the PinPointe™ FootLaser™ has received clearance from the U.S. Food and Drug Administration (FDA) for the treatment of nail fungus (onychomycosis). Dr. Spier is the first certified provider of the treatment in the Baltimore area.
Array BioPharma Inc. today announced that it will present data from a Phase 1 trial of KSP inhibitor ARRY-520 in patients with relapsed/refractory multiple myeloma at the 2010 Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida on Saturday, December 4, 2010.
› Verified 2 days ago
Siham Alzeer-khalifeh, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 554 Blue Ridge Ave Suite 8, Bedford, VA 24523 Phone: 434-455-2480 Fax: 434-455-2487 |